Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NEUROLEPTIC DRUGS' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 147 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Ananth, J; Burgoyne, KS; Gadasalli, R; Aquino, S
      How do the atypical antipsychotics work?

      JOURNAL OF PSYCHIATRY & NEUROSCIENCE
    2. Zahn, TP; Pickar, D; van Kammen, DP
      Neuroleptic effects on autonomic activity in schizophrenia: Between-group and within-subject paradigms and comparisons with controls

      SCHIZOPHRENIA BULLETIN
    3. Kilian, R; Holzinger, A; Angermeyer, MC
      "It may be somewhat more demanding sometimes, but also more interesting". Psychiatrists evaluate the impact of psychoeducation on outpatient treatment of schizophrenia

      PSYCHIATRISCHE PRAXIS
    4. Wadenberg, MLG; Browning, JL; Young, KA; Hicks, PB
      Antagonism at 5-HT2A receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    5. Ellenbroek, BA; Liegeois, JF; Bruhwyler, J; Cools, AR
      Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Jaworski, JN; Gonzales, RA; Randall, PK
      Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    7. Talvik, M; Nordstrom, AL; Nyberg, S; Olsson, H; Halldin, C; Farde, L
      No support for regional selectivity in clozapine-treated patients: A PET study with [C-11]raclopride and [C-11]FLB 457

      AMERICAN JOURNAL OF PSYCHIATRY
    8. Levander, S; Jensen, J; Grawe, R; Tuninger, E
      Schizophrenia - progressive and massive decline in response readiness by episodes

      ACTA PSYCHIATRICA SCANDINAVICA
    9. Tuninger, E; Levander, S
      Neuropsychological impairment in patients treated with depot neuroleptics:a longitudinal study

      ACTA PSYCHIATRICA SCANDINAVICA
    10. Remschmidt, H; Hennighausen, K; Clement, HW; Heiser, P; Schulz, E
      The use of atypical neuroleptic drugs in child and adolescent psychiatry

      ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE
    11. Naber, D; Kasper, S
      The importance of treatment acceptability to patients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    12. Rothermundt, M; Arolt, V; Leadbeater, J; Peters, M; Rudolf, S; Kirchner, H
      Cytokine production in unmedicated and treated schizophrenic patients

      NEUROREPORT
    13. Murphy, CA; Feldon, J
      Low-dose clozapine pretreatment partially prevents haloperidol-induced deficits in conditioned active avoidance

      BEHAVIOURAL PHARMACOLOGY
    14. Baumgartner, A; Pietzcker, A; Gaebel, W
      The hypothalamic-pituitary-thyroid axis in patients with schizophrenia

      SCHIZOPHRENIA RESEARCH
    15. Magnuson, TM; Roccaforte, WH; Wengel, SP; Burke, WJ
      Medication-induced dystonias in nine patients with dementia

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    16. Bauer, R; Mayr, A; Lederer, W; Needham, PL; Kilpatrick, IC; Fleischhacker, WW; Marksteiner, J
      Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs

      NEUROPSYCHOPHARMACOLOGY
    17. Rushlow, WJ; Rajakumar, B; Flumerfelt, BA; Naus, CCG; Rajakumar, N
      Changes in CArG-binding protein A expression levels following injection(s)of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat

      NEUROSCIENCE
    18. Andreassen, OA; Finsen, B; Ostergaard, K; West, MJ; Jorgensen, HA
      Reduced number of striatal neurons expressing preprosomatostatin mRNA in rats with oral dyskinesias after long-term haloperidol administration

      NEUROSCIENCE LETTERS
    19. Guan, HJ; Dai, J; Zhu, XZ
      Atypical antipsychotic effects of quetiapine fumarate in animal models

      ACTA PHARMACOLOGICA SINICA
    20. Ott, MC; Costain, WJ; Mishra, RK; Johnson, RL
      L-prolyl-L-leucyl-glycinamide and its peptidomimetic analog 3 (R)-[(2(S)-pyrrolidylcarbonyl)amino]-2-oxo-1-pyrrolidineacetamide (PAOPA) attenuate haloperidol-induced c-fos expression in the striatum

      PEPTIDES
    21. Crescimanno, G; Mannino, M; Casarrubea, M; Amato, G
      Effects of sulpiride on the orienting movement evoked by acoustic stimulation in the rat

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    22. De Parada, MP; Parada, MA; Rada, P; Hernandez, L; Hoebel, BG
      Dopamine-acetylcholine interaction in the rat lateral hypothalamus in the control of locomotion

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    23. Kunstler, U; Hohdorf, K; Regenthal, R; Seese, A; Gertz, HJ
      Reduction of handwriting area and D-2 dopamine receptor occupancy in therapy with typical and atypical neuroleptic drugs

      NERVENARZT
    24. Kruzich, PJ; See, RE
      An evaluation of the role of 5-MT2 receptor antagonism during subchronic antipsychotic drug administration in rats

      BRAIN RESEARCH
    25. Canales, PL; Olsen, J; Miller, AL; Crismon, ML
      Role of antipsychotic polypharmacotherapy in the treatment of schizophrenia

      CNS DRUGS
    26. Muller-Oerlinghausen, B
      Drug interactions with lithium - A guide for clinicians

      CNS DRUGS
    27. Studenik, C; Lemmens-Gruber, R; Heistracher, P
      Proarrhythmic effects of antidepressants and neuroleptic drugs on isolated, spontaneously beating guinea-pig Purkinje fibers

      EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
    28. Kawashima, N; Nakamura, A; Okuyama, S; Chaki, S; Tomisawa, K
      Effects of NRA0045, NRA0160, and NRA0215 on regional Fos-like immunoreactivity in the rat brain

      GENERAL PHARMACOLOGY
    29. Schmitt, U; Dahmen, N; Fischer, V; Weigmann, H; Rao, ML; Reuss, S; Hiemke, C
      Chronic oral haloperidol and clozapine in rats: A behavioral evaluation

      NEUROPSYCHOBIOLOGY
    30. Colombat, M; Carton, S; Bakhache, B
      Ischaemic colitis and neuroleptics

      REVUE DE MEDECINE INTERNE
    31. Ishibashi, T; Tagashira, R; Nakamura, M; Noguchi, H; Ohno, Y
      Effects of perospirone, a novel 5-HT2 and D-2 receptor antagonist, on Fos protein expression in the rat forebrain

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    32. Cousins, MS; Finn, M; Trevitt, J; Carriero, DL; Conlan, A; Salamone, JD
      The role of ventrolateral striatal acetylcholine in the production of tacrine-induced jaw movements

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    33. Trevitt, JT; Carlson, BB; Salamone, JD
      Behavioral assessment of atypical antipsychotics in rats: studies of the effects of olanzapine (Zyprexa)

      PSYCHOPHARMACOLOGY
    34. ZUMBRUNNEN TL; JANN MW
      DRUG-INTERACTIONS WITH ANTIPSYCHOTIC AGENTS - INCIDENCE AND THERAPEUTIC IMPLICATIONS

      CNS DRUGS
    35. Daigneault, S; Braun, CMJ; Bouffard, R; Villeneuve, L
      Pseudoakathisia from an acquired lesion

      NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY
    36. AHMADIABHARI SA; DEHPOUR AR; EMAMIAN ES; AZIZABADIFARAHANI M; FARSAM H; SAMINI M; SHOKRI J
      THE EFFECT OF CONCURRENT ADMINISTRATION OF PSYCHOTROPIC-DRUGS AND LITHIUM ON LITHIUM RATIO IN BIPOLAR PATIENTS

      Human psychopharmacology
    37. Madsen, M; Lublin, H
      MK-801-induced dystonia in Cebus monkeys

      CLINICAL NEUROPHARMACOLOGY
    38. SADEGHIPOURROUDSARI HR; FARAHANI M; SHOKRGOZAR AA; FARSAM H; DEHPOUR AR
      DECREASE IN ERYTHROCYTE PLASMA LITHIUM RATIO BY CONCURRENT ADMINISTRATION OF PSYCHOTROPIC-DRUGS AND LITHIUM IN MICE/

      General pharmacology
    39. CAZZULLO CL; SCARONE S; GRASSI B; VISMARA C; TRABATTONI D; CLERICI M; CLERICI M
      CYTOKINES PRODUCTION IN CHRONIC-SCHIZOPHRENIA PATIENTS WITH OR WITHOUT PARANOID BEHAVIOR

      Progress in neuro-psychopharmacology & biological psychiatry
    40. DEHPOUR AR; EMAMIAN ES; AMADIABHARI SA; AZIZABADIFARAHANI M
      THE LITHIUM RATIO AND THE INCIDENCE OF SIDE-EFFECTS

      Progress in neuro-psychopharmacology & biological psychiatry
    41. HERTEL P; LINDBLOM N; NOMIKOS GG; SVENSSON TH
      MODULATION OF CENTRAL SEROTONERGIC NEUROTRANSMISSION BY RISPERIDONE -UNDERLYING MECHANISM[S] AND SIGNIFICANCE OF ACTION

      Progress in neuro-psychopharmacology & biological psychiatry
    42. Sachdev, PS; Saharov, T
      Effects of specific dopamine D-1 and D-2 receptor antagonists and agonistsand neuroleptic drugs on emotional defecation in a rat model of akathisia

      PSYCHIATRY RESEARCH
    43. COUSINS MS; ATHERTON A; SALAMONE JD
      BEHAVIORAL AND ELECTROMYOGRAPHIC CHARACTERIZATION OF THE LOCAL FREQUENCY OF TACRINE-INDUCED TREMULOUS JAW MOVEMENTS

      Physiology & behavior
    44. Guitart, X; Farre, AJ
      The effect of E-5842, a sigma receptor ligand and potential atypical antipsychotic, on Fos expression in rat forebrain

      EUROPEAN JOURNAL OF PHARMACOLOGY
    45. KALKMAN HO; NEUMANN V; HOYER D; TRICKLEBANK MD
      THE ROLE OF ALPHA(2)-ADRENOCEPTOR ANTAGONISM IN THE ANTI-CATALEPTIC PROPERTIES OF THE ATYPICAL NEUROLEPTIC AGENT, CLOZAPINE, IN THE RAT

      British Journal of Pharmacology
    46. GRIMM JW; SEE RE
      UNIQUE ACTIVATION OF EXTRACELLULAR STRIATOPALLIDAL NEUROTRANSMITTERS IN RATS FOLLOWING ACUTE RISPERIDONE

      Brain research
    47. PASCALIS JG; RAUCOULES D; THERET L
      OGILVIES-SYNDROME IN SCHIZOPHRENICS - INV OLVEMENT OF ANTIPSYCHOTICS

      Annales medico-psychologiques
    48. SHIWACH RS; CARMODY TJ
      PROLACTOGENIC EFFECTS OF RISPERIDONE IN MALE-PATIENTS - A PRELIMINARY-STUDY

      Acta psychiatrica Scandinavica
    49. BRUHWYLER J; LIEGEOIS JF; BERGMAN J; CAREY G; GOUDIE A; TAYLOR A; MELTZER H; DELARGE J; GECZY J
      JL13, A PYRIDOBENZOXAZEPINE COMPOUND WITH POTENTIAL ATYPICAL ANTIPSYCHOTIC ACTIVITY - A REVIEW OF ITS BEHAVIORAL PROPERTIES

      Pharmacological research
    50. LEE SH; OH DY; JUNG SC; KIM YM; CHO HK; KOH JK; LEE YS
      NEUROLEPTIC DRUGS ALTER THE DOPAMINE TRANSPORTER-MEDIATED UPTAKE AND RELEASE OF DOPAMINE - A POSSIBLE MECHANISM FOR DRUG-INDUCED TARDIVE-DYSKINESIA

      Pharmacological research
    51. EBERLEINKONIG B; BINDL A; PRZYBILLA B
      PHOTOTOXIC PROPERTIES OF NEUROLEPTIC DRUGS

      Dermatology
    52. CHANG WH; LIN SK; LANE HY; HU WH; JANN MW; LIN HN
      CLOZAPINE DOSAGES AND PLASMA DRUG CONCENTRATIONS

      Journal of the Formosan Medical Association
    53. FARDE L
      BRAIN IMAGING OF SCHIZOPHRENIA - THE DOPAMINE HYPOTHESIS

      Schizophrenia research
    54. WALTERS VL; TOGNOLINI RZ; RUEDA HM; RUEDA RM; TORRES RG
      NEW STRATEGIES FOR OLD PROBLEMS - TARDIVE-DYSKINESIA (TD) - REVIEW AND REPORT ON SEVERE TD CASES TREATED WITH CLOZAPINE, WITH 12, 8 AND 5 YEARS OF VIDEO FOLLOW-UP

      Schizophrenia research
    55. HERTEL P; NOMIKOS GG; SCHILSTROM B; ARBORELIUS L; SVENSSON TH
      RISPERIDONE DOSE-DEPENDENTLY INCREASES EXTRACELLULAR CONCENTRATIONS OF SEROTONIN IN THE RAT FRONTAL-CORTEX - ROLE OF ALPHA(2)-ADRENOCEPTOR ANTAGONISM

      Neuropsychopharmacology
    56. TARSY D; KAUFMAN D; SETHI KD; RIVNER MH; MOLHO E; FACTOR S
      AN OPEN-LABEL STUDY OF BOTULINUM TOXIN-A FOR TREATMENT OF TARDIVE-DYSTONIA

      Clinical neuropharmacology
    57. MESZAROS K; LENZINGER E; HORNIK K; SCHONBECK G; HATZINGER R; LANGER G; SIEGHART W; ASCHAUER HN
      BIPERIDEN AND HALOPERIDOL PLASMA-LEVELS AND EXTRAPYRAMIDAL SIDE-EFFECTS IN SCHIZOPHRENIC-PATIENTS

      Neuropsychobiology
    58. WILLNER P
      THE DOPAMINE HYPOTHESIS OF SCHIZOPHRENIA - CURRENT STATUS, FUTURE-PROSPECTS

      International clinical psychopharmacology
    59. STEINPREIS RE; PARRET F; SUMM RM; PANOS JJ
      EFFECTS OF CLOZAPINE AND HALOPERIDOL ON BASE-LINE LEVELS OF VACUOUS JAW MOVEMENTS IN AGED RATS

      Behavioural brain research
    60. PANDEY GN; CONLEY RR; PANDEY SC; GOEL S; ROBERTS RC; TAMMINGA CA; CHUTE D; SMIALEK J
      BENZODIAZEPINE RECEPTORS IN THE POSTMORTEM BRAIN OF SUICIDE VICTIMS AND SCHIZOPHRENIC SUBJECTS

      Psychiatry research
    61. CARRIERO DL; OUTSLAY G; MAYORGA AJ; ABERMAN J; GIANUTSOS G; SALAMONE JD
      MOTOR DYSFUNCTION PRODUCED BY TACRINE ADMINISTRATION IN RATS

      Pharmacology, biochemistry and behavior
    62. FINN M; JASSEN A; BASKIN P; SALAMONE JD
      TREMULOUS CHARACTERISTICS OF THE VACUOUS JAW MOVEMENTS INDUCED BY PILOCARPINE AND VENTROLATERAL STRIATAL DOPAMINE DEPLETIONS

      Pharmacology, biochemistry and behavior
    63. MAYORGA AJ; CARRIERO DL; COUSINS MS; GIANUTSOS G; SALAMONE JD
      TREMULOUS JAW MOVEMENTS PRODUCED BY ACUTE TACRINE ADMINISTRATION - POSSIBLE RELATION TO PARKINSONIAN SIDE-EFFECTS

      Pharmacology, biochemistry and behavior
    64. BAKHEIT AMO
      THE SYNDROME OF MOTOR RESTLESSNESS - A TREATABLE BUT UNDER-RECOGNIZEDDISORDER

      Postgraduate medical journal
    65. PARADA MA; HERNANDEZ L; DEPARADA MP; RADA P; MURZI E
      SELECTIVE ACTION OF ACUTE SYSTEMIC CLOZAPINE ON ACETYLCHOLINE-RELEASEIN THE RAT PREFRONTAL CORTEX BY REFERENCE TO THE NUCLEUS-ACCUMBENS AND STRIATUM

      The Journal of pharmacology and experimental therapeutics
    66. PERRAULT G; DEPOORTERE R; MOREL E; SANGER DJ; SCATTON B
      PSYCHOPHARMACOLOGICAL PROFILE OF AMISULPRIDE - AN ANTIPSYCHOTIC DRUG WITH PRESYNAPTIC D-2 D-3 DOPAMINE-RECEPTOR ANTAGONIST ACTIVITY AND LIMBIC SELECTIVITY/

      The Journal of pharmacology and experimental therapeutics
    67. CHO S; NEFF NH; HADJICONSTANTINOU M
      REGULATION OF TYROSINE-HYDROXYLASE AND AROMATIC L-AMINO-ACID DECARBOXYLASE BY DOPAMINERGIC DRUGS

      European journal of pharmacology
    68. HERTEL P; NOMIKOS GG; SVENSSON TH
      RISPERIDONE INHIBITS 5-HYDROXYTRYPTAMINERGIC NEURONAL-ACTIVITY IN THEDORSAL RAPHE NUCLEUS BY LOCAL RELEASE OF 5-HYDROXYTRYPTAMINE

      British Journal of Pharmacology
    69. PINNA A; WARDAS J; CRISTALLI G; MORELLI M
      ADENOSINE A(2A) RECEPTOR AGONISTS INCREASE FOS-LIKE IMMUNOREACTIVITY IN MESOLIMBIC AREAS

      Brain research
    70. VANOS J; FAHY T; JONES P; HARVEY I; TOONE B; MURRAY R
      TARDIVE-DYSKINESIA - WHO IS AT RISK

      Acta psychiatrica Scandinavica
    71. KIROV GK; MURRAY RM; SETH RV; FEENEY S
      OBSERVATIONS ON SWITCHING PATIENTS WITH SCHIZOPHRENIA TO RISPERIDONE TREATMENT

      Acta psychiatrica Scandinavica
    72. TREVITT JT; LYONS M; ABERMAN J; CARRIERO D; FINN M; SALAMONE JD
      EFFECTS OF CLOZAPINE, THIORIDAZINE, RISPERIDONE AND HALOPERIDOL ON BEHAVIORAL-TESTS RELATED TO EXTRAPYRAMIDAL MOTOR FUNCTION

      Psychopharmacology
    73. SANGER DJ; DEPOORTERE R; PERRAULT G
      EVIDENCE FOR A ROLE FOR DOPAMINE D3 RECEPTORS IN THE EFFECTS OF DOPAMINE AGONISTS ON OPERANT-BEHAVIOR IN RATS

      Behavioural pharmacology
    74. MIJNSTER MJ; INGHAM CA; MEREDITH GE; DOCTOR GJ; ARBUTHNOTT GW
      MORPHOLOGICAL-CHANGES IN MET(5)-ENKEPHALIN-IMMUNOREACTIVE SYNAPTIC BOUTONS IN THE RAT NEOSTRIATUM AFTER HALOPERIDOL DECANOATE TREATMENT

      European journal of neuroscience
    75. BONSACK CL; PHILIPPOZ R
      OUTPATIENT TREATMENT OF ACUTE PSYCHOTIC EPISODE WITH NEUROLEPTIC INFUSIONS - A RETROSPECTIVE STUDY

      European psychiatry
    76. ELLENBROEK BA; LUBBERS LJ; COOLS AR
      ACTIVITY OF SEROQUEL (ICI204,636) IN ANIMAL-MODELS FOR ATYPICAL PROPERTIES OF ANTIPSYCHOTICS - A COMPARISON WITH CLOZAPINE

      Neuropsychopharmacology
    77. MERELLO M; STARKSTEIN S; PETRACCA G; CATANEO EA; MANES F; LEIGUARDA R
      DRUG-INDUCED PARKINSONISM IN SCHIZOPHRENIC-PATIENTS - MOTOR RESPONSE AND PSYCHIATRIC CHANGES AFTER ACUTE CHALLENGE WITH L-DOPA AND APOMORPHINE

      Clinical neuropharmacology
    78. DEUTCH AY; DUMAN RS
      THE EFFECTS OF ANTIPSYCHOTIC-DRUGS ON FOS PROTEIN EXPRESSION IN THE PREFRONTAL CORTEX - CELLULAR-LOCALIZATION AND PHARMACOLOGICAL CHARACTERIZATION

      Neuroscience
    79. NEUMAN E; RANCUREL G; LECRUBIER Y; FOHANNO D; BOLLER F
      SCHIZOPHRENIFORM CATATONIA ON 6 CASES SECONDARY TO HYDROCEPHALUS WITHSUBTHALAMIC MESENCEPHALIC TUMOR-ASSOCIATED WITH HYPODOPAMINERGIA

      Neuropsychobiology
    80. NAYLOR L; DEAN B; OPESKIN K; PAVEY G; HILL C; KEKS N; COPOLOV D
      CHANGES IN THE SEROTONIN TRANSPORTER IN THE HIPPOCAMPUS OF SUBJECTS WITH SCHIZOPHRENIA IDENTIFIED USING [H-3] PAROXETINE

      Journal of neural transmission
    81. GRUNZE H; WALDEN J; WOLF R; BERGER M
      COMBINED TREATMENT WITH LITHIUM AND NIMODIPINE IN A BIPOLAR-I MANIC SYNDROME

      Progress in neuro-psychopharmacology & biological psychiatry
    82. DEAN B; SUNDRAM S; HILL C; COPOLOV DL
      PLATELET [H-3]DOPAMINE UPTAKE IS DIFFERENTIALLY AFFECTED BY NEUROLEPTIC DRUG-TREATMENT IN SCHIZOPHRENIA AND SCHIZOPHRENIFORM DISORDER

      Progress in neuro-psychopharmacology & biological psychiatry
    83. SEDVALL GC
      NEUROBIOLOGICAL CORRELATES OF ACUTE NEUROLEPTIC TREATMENT

      International clinical psychopharmacology
    84. LIU HC; CHANG WH; WEI FC; LIN SK; LIN SK; JANN MW
      MONITORING OF PLASMA CLOZAPINE LEVELS AND ITS METABOLITES IN REFRACTORY SCHIZOPHRENIC-PATIENTS

      Therapeutic drug monitoring
    85. CHESLER EJ; SALAMONE JD
      EFFECTS OF ACUTE AND REPEATED CLOZAPINE INJECTIONS ON CHOLINOMIMETIC-INDUCED VACUOUS JAW MOVEMENTS

      Pharmacology, biochemistry and behavior
    86. SALAMONE J; BASKIN P
      VACUOUS JAW MOVEMENTS INDUCED BY ACUTE RESERPINE AND LOW-DOSE APOMORPHINE - POSSIBLE MODEL OF PARKINSONIAN TREMOR

      Pharmacology, biochemistry and behavior
    87. KOYTCHEV R; ALKEN RG; MCKAY G; KATZAROV T
      ABSOLUTE BIOAVAILABILITY OF ORAL IMMEDIATE AND SLOW-RELEASE FLUPHENAZINE IN HEALTHY-VOLUNTEERS

      European Journal of Clinical Pharmacology
    88. KEHNE JH; BARON BM; CARR AA; CHANEY SF; ELANDS J; FELDMAN DJ; FRANK RA; VANGIERSBERGEN PLM; MCCLOSKEY TC; JOHNSON MP; MCCARTY DR; POIROT M; SENYAH Y; SIEGEL BW; WIDMAIER C
      PRECLINICAL CHARACTERIZATION OF THE POTENTIAL OF THE PUTATIVE ATYPICAL ANTIPSYCHOTIC MDL-100,907 AS A POTENT 5-HT2A ANTAGONIST WITH A FAVORABLE CNS SAFETY PROFILE

      The Journal of pharmacology and experimental therapeutics
    89. BOCOLA V; FABBRINI G; SOLLECITO A; PALADINI C; MARTUCCI N
      NEUROLEPTIC-INDUCED PARKINSONISM - MRI FINDINGS IN RELATION TO CLINICAL COURSE AFTER WITHDRAWAL OF NEUROLEPTIC DRUGS

      Journal of Neurology, Neurosurgery and Psychiatry
    90. VANDERSTAAY FJ; AUGSTEIN KH; HORVATH E
      SENSORIMOTOR IMPAIRMENTS IN RATS WITH CEREBRAL INFARCTION, INDUCED BYUNILATERAL OCCLUSION OF THE LEFT MIDDLE CEREBRAL-ARTERY - STRAIN DIFFERENCES AND EFFECTS OF THE OCCLUSION SITE

      Brain research
    91. CERVO L; SAMANIN R
      EFFECTS OF DOPAMINERGIC AND GLUTAMATERGIC RECEPTOR ANTAGONISTS ON THEESTABLISHMENT AND EXPRESSION OF CONDITIONED LOCOMOTION TO COCAINE IN RATS

      Brain research
    92. VANDERSTAAY FJ; AUGSTEIN KH; HORVATH E
      SENSORIMOTOR IMPAIRMENTS IN WISTAR-KYOTO RATS WITH CEREBRAL INFARCTION, INDUCED BY UNILATERAL OCCLUSION OF THE MIDDLE CEREBRAL-ARTERY - RECOVERY OF FUNCTION

      Brain research
    93. WANG ZR; REBEC GV
      AMYGDALOID NEURONS RESPOND TO CLOZAPINE RATHER THAN HALOPERIDOL IN BEHAVING RATS PRETREATED WITH INTRA-AMYGDALOID AMPHETAMINE

      Brain research
    94. PRINSSEN EPM; KLEVEN MS; KOEK W
      EFFECTS OF DOPAMINE ANTAGONISTS IN A 2 WAY ACTIVE-AVOIDANCE PROCEDUREIN RATS - INTERACTIONS WITH 8-OH-DPAT, RITANSERIN, AND PRAZOSIN

      Psychopharmacology
    95. FENN DS; MOUSSAOUI D; HOFFMAN WF; KADRI N; BENTOUNSSI B; TILANE A; KHOMEIS M; CASEY DE
      MOVEMENTS IN NEVER-MEDICATED SCHIZOPHRENICS - A PRELIMINARY-STUDY

      Psychopharmacology
    96. BEHL C; RUPPRECHT R; SKUTELLA T; HOLSBOER F
      HALOPERIDOL-INDUCED CELL DEATH-MECHANISM AND PROTECTION WITH VITAMIN-E IN-VITRO

      NeuroReport
    97. LAMBERT T; KEKS N; MCGRATH J; CATTS S; HUSTIG H; VADDADI K; BURROWS G; VARGHESE F; GEORGE T; KERR K; JOHNSON G; BURNETT P; ZORBAS A; HILL C; COPOLOV D
      REMOXIPRIDE VERSUS THIORIDAZINE IN THE TREATMENT OF FIRST EPISODES OFSCHIZOPHRENIA IN DRUG-NAIVE PATIENTS - A CASE FOR SPECIFIC, LOW POTENCY D-2 ANTAGONISTS

      Human psychopharmacology
    98. BHARUCHA KJ; SETHI KD
      TARDIVE TOURETTISM AFTER EXPOSURE TO NEUROLEPTIC THERAPY

      Movement disorders
    99. FINLEY PR; WARNER MD; PEABODY CA
      CLINICAL RELEVANCE OF DRUG-INTERACTIONS WITH LITHIUM

      Clinical pharmacokinetics
    100. CEBALLOSBAUMANN AO; CONRAD B
      DRUG-INDUCED DYSKINESIAS

      Aktuelle Neurologie


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 14:59:45